0001415889-24-019936.txt : 20240723 0001415889-24-019936.hdr.sgml : 20240723 20240723163710 ACCESSION NUMBER: 0001415889-24-019936 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240722 FILED AS OF DATE: 20240723 DATE AS OF CHANGE: 20240723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaBrosse Nicole CENTRAL INDEX KEY: 0001910662 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32335 FILM NUMBER: 241134890 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001159036 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880488686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 794-8889 MAIL ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC DATE OF NAME CHANGE: 20040312 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC DATE OF NAME CHANGE: 20010912 4 1 form4-07232024_080706.xml X0508 4 2024-07-22 0001159036 HALOZYME THERAPEUTICS, INC. HALO 0001910662 LaBrosse Nicole C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130 false true false false SVP, CHIEF FINANCIAL OFFICER 1 Common Stock 2024-07-22 4 M 0 4008 22.50 A 19488 D Common Stock 2024-07-22 4 S 0 4008 53.853 D 15480 D Common Stock 2024-07-22 4 M 0 992 22.50 A 16472 D Common Stock 2024-07-22 4 S 0 992 54.253 D 15480 D Option to Purchase Common Stock 22.50 2024-07-22 4 M 0 5000 0 D 2025-07-01 Common Stock 5000 0 D The option exercises and sales reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2024. Represents a weighted average sales price per share. These shares were sold at prices ranging from $53.17 to $54.15. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. These shares were sold at prices ranging from $54.17 to $54.325. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. This option was granted on July 1, 2015 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. /s/ James R. Oehler, Attorney-in-Fact 2024-07-23